Harbin Pharma
Harbin Pharma, officially known as Harbin Pharmaceutical Group Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in Harbin, China. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including traditional Chinese medicine, chemical drugs, and biopharmaceuticals. With a strong presence in both domestic and international markets, Harbin Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a variety of prescription medications and over-the-counter products, distinguished by their efficacy and adherence to stringent safety standards. Notably, Harbin Pharma has achieved several milestones, positioning itself as a leader in the industry and contributing to advancements in healthcare solutions.
DitchCarbon Score
How does Harbin Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Harbin Pharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Harbin Pharma's reported carbon emissions
Harbin Pharma, headquartered in China (CN), currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for Harbin Pharma to establish clear emissions reduction goals and transparent reporting to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Harbin Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
